Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112346
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2005-06-01
Brief Title:
Study of GemcitabinePlatinum - Cetuximab as First-Line Treatment for Patients With AdvancedMetastatic Non-Small Cell Lung Cancer
Sponsor:
Organization:
Eli Lilly and Company